Exclusive LinkedIn data shows engineering majors have been hit hard in today’s weak, AI-affected job market. Here’s what specialties are hurting the most.
Marketing leader Ryan Gavin of Salesforce and Slack shared insights on how organizations can drive lasting AI performance and productivity.
Nearly a decade after the much-publicized rise and fall of Jibo, the product has a spiritual successor named iKairos. This time it’ll be more capable.
America’s biggest oil field produces lots of dirty water and cheap natural gas. That makes West Texas a perfect location for data centers, says David Capobianco.
Marc Tarpenning and Martin Eberhard dreamed up Tesla, then convinced Elon Musk to fund it. Two decades later, they’re backing TELO, a maker of pint-sized electric trucks.
AI Startup Corgi Fundraises Yet Again, At $4 Billion Valuation
Thanks to a quirky financial regulation, the Discover deal is already generating significant incremental revenue.
In this week’s edition of InnovationRx, we look at the companies looking to cash in on the coming peptide bonanza, the ongoing cyclosporiasis outbreak, Tempus’s acquisition of a cancer-testing company, and more.
With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and telehealth companies are preparing for the coming bonanza.
More than 600,000 police reports have been written with help from Axon’s AI tools. Public records obtained by Forbes show that they can introduce errors that cops have to spend time editing out.